... detecting undernutrition. 5.2.7.2. Consideration of clinical benefits and harms The Committee acknowledged the evidence presented ... function. 5.3.2.7.2. Consideration of clinical benefits and harms The Committee acknowledged the multifactorial origin ...

... adrenal insufficiency. 10.1.7.2. Consideration of clinical benefits and harms People with cystic fibrosis often suffer ... important outcomes. 10.2.7.2. Consideration of clinical benefits and harms The committee noted that pancreatic enzyme ...

... life. 11.1.1.6.2. Consideration of clinical benefits and harms Pain is a common symptom of ... practice. 11.1.2.6.2. Consideration of clinical benefits and harms The Committee agreed that it was ...

... as important. 9.1.7.2. Consideration of clinical benefits and harms The committee acknowledged the scarcity of ... important outcomes. 9.2.7.2. Consideration of clinical benefits and harms The committee acknowledged the evidence, but ...

... as bronchiolitis is a clinical syndrome. Consideration of clinical benefits and harms Evidence for signs and symptoms of ... or healthcare professional concerns in general. Consideration of clinical benefits and harms The Committee noted that this evidence ...

... education services. 5.2.8.2. Consideration of clinical benefits and harms Information about prematurity and the potential ... the evidence. 5.3.8.2. Consideration of clinical benefits and harms The Committee agreed that the evidence ...

... R1 rates. 10.1.8.3. Consideration of clinical benefits and harms Given the limited, low quality evidence ... this time. 10.3.8.3. Consideration of clinical benefits and harms The committee noted, based on directly ...

... positive likelihood ratios were examined. Trade-off between clinical benefits and harms The GDG agreed that the evidence ... included use of restrictive interventions. Trade-off between clinical benefits and harms The GDG agreed that management strategies ...

... was identified. 5.1.7.2. Consideration of clinical benefits and harms The Committee acknowledged that although the ... was identified. 5.2.7.2. Consideration of clinical benefits and harms As clinical evidence was not identified ...

... and their families and carers. Trade off between clinical benefit and harms The GDG felt that restriction of ... wanted by children and families. Trade off between clinical benefit and harms No evidence of harms . Economic considerations ...